Literature DB >> 28728476

A perspective on diuretic resistance in chronic congestive heart failure.

Niel Shah1, Raef Madanieh1, Mehmet Alkan2, Muhammad U Dogar1, Constantine E Kosmas3, Timothy J Vittorio4.   

Abstract

Chronic congestive heart failure (CHF) is a complex disorder characterized by inability of the heart to keep up the demands on it, followed by the progressive pump failure and fluid accumulation. Although the loop diuretics are widely used in heart failure (HF) patients, both pharmacodynamic and pharmacokinetic alterations are thought to be responsible for diuretic resistance in these patients. Strategies to overcome diuretic resistance include sodium intake restriction, changes in diuretic dose and route of administration and sequential nephron diuretic therapy. In this review, we discuss the definition, prevalence, mechanism of development and management strategies of diuretic resistance in HF patients.

Entities:  

Keywords:  cardiorenal syndrome; diuretic resistance; diuretics; heart failure; renal failure

Mesh:

Substances:

Year:  2017        PMID: 28728476      PMCID: PMC5933583          DOI: 10.1177/1753944717718717

Source DB:  PubMed          Journal:  Ther Adv Cardiovasc Dis        ISSN: 1753-9447


  53 in total

1.  Mechanism of impaired natriuretic response to furosemide during prolonged therapy.

Authors:  N R Loon; C S Wilcox; R J Unwin
Journal:  Kidney Int       Date:  1989-10       Impact factor: 10.612

2.  Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion.

Authors:  T P Dormans; J J van Meyel; P G Gerlag; Y Tan; F G Russel; P Smits
Journal:  J Am Coll Cardiol       Date:  1996-08       Impact factor: 24.094

Review 3.  The physiologic basis of diuretic synergism: its role in treating diuretic resistance.

Authors:  D H Ellison
Journal:  Ann Intern Med       Date:  1991-05-15       Impact factor: 25.391

4.  Role of duration of diuretic effect in preventing sodium retention.

Authors:  J A Ferguson; K J Sundblad; P K Becker; J C Gorski; D W Rudy; D C Brater
Journal:  Clin Pharmacol Ther       Date:  1997-08       Impact factor: 6.875

Review 5.  Ototoxicity of loop diuretics.

Authors:  L P Rybak
Journal:  Otolaryngol Clin North Am       Date:  1993-10       Impact factor: 3.346

6.  Aspirin-induced depression of renal function.

Authors:  R P Kimberly; P H Plotz
Journal:  N Engl J Med       Date:  1977-02-24       Impact factor: 91.245

7.  Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance.

Authors:  J J van Meyel; P Smits; T Dormans; P G Gerlag; F G Russel; F W Gribnau
Journal:  J Intern Med       Date:  1994-04       Impact factor: 8.989

8.  Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor.

Authors:  A A van Vliet; A J Donker; J J Nauta; F W Verheugt
Journal:  Am J Cardiol       Date:  1993-01-21       Impact factor: 2.778

9.  The effects of diuresis on the pharmacokinetics of the loop diuretics furosemide and torsemide in patients with heart failure.

Authors:  S S Gottlieb; M Khatta; D Wentworth; D Roffman; M L Fisher; W G Kramer
Journal:  Am J Med       Date:  1998-06       Impact factor: 4.965

10.  Metolazone in treatment of severe refractory congestive cardiac failure.

Authors:  A Kiyingi; M J Field; C C Pawsey; J Yiannikas; J R Lawrence; W J Arter
Journal:  Lancet       Date:  1990-01-06       Impact factor: 79.321

View more
  9 in total

Review 1.  Loop diuretics in chronic heart failure: how to manage congestion?

Authors:  Justas Simonavičius; Christian Knackstedt; Hans-Peter Brunner-La Rocca
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

Review 2.  Comprehensive and Safe Decongestion in Acutely Decompensated Heart Failure.

Authors:  Jason Stencel; Indranee Rajapreyar; Rohan Samson; Thierry Le Jemtel
Journal:  Curr Heart Fail Rep       Date:  2022-09-01

3.  Impact of Outpatient Diuretic Infusion Therapy on Healthcare Cost and Readmissions.

Authors:  Nandini Nair; Nandini Ray; Pavida Pachariyanon; Ryan Burden; Nicholas Skeen
Journal:  Int J Heart Fail       Date:  2022-01-11

4.  Clinical significance of sFRP5, RBP-4 and NT-proBNP in patients with chronic heart failure.

Authors:  Yu An; Qingsong Wang; Hong Wang; Na Zhang; Fengming Zhang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

5.  Induction of renal tumor necrosis factor-α and other autacoids and the beneficial effects of hypertonic saline in acute decompensated heart failure.

Authors:  Stergios Gatzoflias; Shoujin Hao; Nicholas R Ferreri
Journal:  Am J Physiol Renal Physiol       Date:  2021-05-10

6.  Successful treatment of refractory edema with traditional herbal medicine: A case report.

Authors:  Gayoung Lee; Jung-Hyo Cho; Chang-Gue Son; Namhun Lee
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

Review 7.  Diuretic Resistance Associated With Heart Failure.

Authors:  Elham Shams; Sabrina Bonnice; Harvey N Mayrovitz
Journal:  Cureus       Date:  2022-01-18

8.  Intensification of pharmacological decongestion but not the actual daily loop diuretic dose predicts worse chronic heart failure outcome: insights from TIME-CHF.

Authors:  Justas Simonavičius; Micha T Maeder; Casper G M J Eurlings; Arantxa Barandiarán Aizpurua; Jelena Čelutkienė; Jūratė Barysienė; Stefan Toggweiler; Beat A Kaufmann; Hans-Peter Brunner-La Rocca
Journal:  Clin Res Cardiol       Date:  2020-11-20       Impact factor: 5.460

9.  N-Aryl-7-hydroxy-5-oxo-2,3-dihydro-1H,5H-pyrido-[3,2,1-ij]quinoline-6-carboxamides. The Synthesis and Effects on Urinary Output.

Authors:  Igor V Ukrainets; Lyudmila V Sidorenko; Mykola Y Golik; Igor M Chernenok; Lina A Grinevich; Alexandra A Davidenko
Journal:  Sci Pharm       Date:  2018-04-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.